The Recall Desk
ModerateFDA (Drugs)·D-0542-2025·Announced 2025-08-06

Amlodipine and benazepril capsules released with the wrong expiry date

Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg are being recalled because they were released with the wrong expiry date, printed as February 2027 instead of January 2027. 7,668 bottles affected.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall for an expiry date printed one month later than it should be, which is a labeling error with no product defect stated.

Plain-English summary

Amlodipine and Benazepril HCl Capsules USP, 2.5 mg/10 mg, 100 capsule bottles, prescription only, manufactured for Lupin Pharmaceuticals, Inc. of Naples, Florida by Lupin Limited of Goa, India, are being recalled. The action covers 7,668 bottles.

The stated reason is a labeling issue of incorrect or missing lot and/or expiry date: the product was released with the wrong expiry date, printed as February 2027 instead of January 2027. The FDA classified the action as Class II. The source does not describe any defect in the product itself.

The affected lot is GB01616. Distribution was nationwide in the US.

Patients holding the affected lot should speak to their pharmacist before stopping treatment, and pharmacies should follow the instructions issued by Lupin.

The recalled product

Product
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)
Brand
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Affected units
7,668

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot GB01616
  • expiration 2/28/2027

UPCs (1)

  • 0368180459019

Distribution

Distributed nationwide across the United States.

Same brand · AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE